Нидерланды - английский - HMA (Heads of Medicines Agencies)

ceva santé animale - infectious bronchitis virus 2.8 eid50/dose - oral lyophilisate - chicken broilers, chicken layers - immunologicals

Португалия - английский - HMA (Heads of Medicines Agencies)

ceva santé animale - infectious bronchitis virus 2.8 eid50/dose - oral lyophilisate - chicken broilers, chicken layers - immunologicals

Румыния - английский - HMA (Heads of Medicines Agencies)

ceva santé animale - infectious bronchitis virus 2.8 eid50/dose - oral lyophilisate - chicken broilers, chicken layers - immunologicals

Словения - английский - HMA (Heads of Medicines Agencies)

ceva santé animale - infectious bronchitis virus 2.8 eid50/dose - oral lyophilisate - chicken broilers, chicken layers - immunologicals

Великобритания - английский - HMA (Heads of Medicines Agencies)

ceva santé animale - infectious bronchitis virus 2.8 eid50/dose - oral lyophilisate - chicken broilers, chicken layers - immunologicals

Ирландия - английский - HPRA (Health Products Regulatory Authority)

ceva santé animale - live attenuated infectious bronchitis (ib) virus, strain 1/96, variant subtype - lyophilisate for oculonasal suspension/use in drinking water - . - avian infectious bronchitis virus - chickens - immunological - live vaccine

Европейский союз - английский - EMA (European Medicines Agency)

ceva santé animale - benazepril hydrochloride, spironolactone - cardiovascular system - dogs - for the treatment of congestive heart failure caused by chronic degenerative valvular disease in dogs (with diuretic support as appropriate).

Европейский союз - английский - EMA (European Medicines Agency)

ceva santé animale - inactivated coxiella burnetii vaccine, strain nine mile - immunologicals for bovidae, inactivated bacterial vaccines (including mycoplasma, toxoid and chlamydia) - goats; cattle - cattle: , for the active immunisation of cattle to lower the risk for non-infected animals vaccinated when non-pregnant to become shedder (5 times lower probability in comparison with animals receiving a placebo), and to reduce shedding of coxiella burnetii in these animals via milk and vaginal mucus., onset of immunity: not established., duration of immunity: 280 days after completion of the primary vaccination course. , goats: , for the active immunisation of goats to reduce abortion caused by coxiella burnetii and to reduce shedding of the organism via milk, vaginal mucus, faeces and placenta., onset of immunity: not established., duration of immunity: one year after completion of the primary vaccination course.

Европейский союз - английский - EMA (European Medicines Agency)

ceva santé animale - genetically modified recombinant shiga-toxin-2e antigen - immunologicals for suidae, inactivated bacterial vaccines (including mycoplasma, toxoid and chlamydia) - pigs - active immunisation of piglets from the age of four days, to reduce the mortality and clinical signs of oedema disease caused by shiga toxin 2e produced by escherichia coli (stec). onset of immunity: 21 days after vaccination. duration of immunity: 105 days after vaccination.,

Европейский союз - английский - EMA (European Medicines Agency)

ceva santé animale - inactivated influenza-a virus / swine - immunologicals - pigs - active immunisation of pigs from the age of 56 days onwards, including pregnant sows, against swine influenza caused by subtypes h1n1, h3n2 and h1n2 to reduce clinical signs and viral lung load after infection.onset of immunity: 7 days after primary vaccinationduration of immunity: 4 months in pigs vaccinated between the age of 56 and 96 days and 6 months in pigs vaccinated for the first time at 96 days and above.active immunisation of pregnant sows after finished primary immunisation by administration of a single dose 14 days prior to farrowing to develop high colostral immunity, which provides clinical protection of piglets for at least 33 days after birth.